| 5 | 1/1 | 返回列表 |
| 查看: 3184 | 回復(fù): 14 | |||
| 當(dāng)前只顯示滿足指定條件的回帖,點(diǎn)擊這里查看本話題的所有回帖 | |||
[交流]
JPBA 投稿被拒,貼出拒稿信,求指點(diǎn) 已有5人參與
|
|||
|
Dear Dr. Zhu, I regret to inform you that, after consideration of our reviewers' comments on your paper (with which I fully agree), I'm unable to accept it for publication. For your guidance, I append the reviewers' comments below. Please note that a great many more papers are submitted to JPBA than we can possibly publish. The acceptance rate for papers is about 25% and our decision is not a reflection of the quality of your research but rather of our stringent requirements. The Editors hope that you do understand the above decision, and we appreciate your continued interest in the Journal of Pharmaceutical and Biomedical Analysis. Thank you for giving us the opportunity to consider your work. We wish you every success when you submit the paper elsewhere. Yours sincerely, Sándor Görög Editor Journal of Pharmaceutical and Biomedical Analysis Reviewers' comments: Reviewer #1: This paper is about Identification of major compounds in rat bile, plasma and urine after oral administration of Radix Scutellariae extract by ultra-fast liquid chromatography coupled to ion trap time-of-flight mass spectrometry. Although these observation are interesting, they are rather limited and do not advance our knowledge of the subject sufficiently to warrant publication in JPBA. 1. It is noted that your manuscript needs careful editing by someone with expertise in technical English editing paying particular attention to English grammar, spelling, and sentence structure. 2. The innovation of this manuscript is weak and the content of experiments is not plentiful. 3. The Fig.4 and Fig.4 are not clearly expressed, and the Fig.5 should be deleted. It will be nice if you can add the schematic diagram of the cracking. Based on what was described above this manuscript is not suitable for publication in the journal of JPBA. We suggest that the authors try submitting their findings to other journals. Reviewer #2: I do not recommend the publication of this manuscript due mainly to the lack of scientific novelty and for neglecting the comparison of the authors' method and results with those in the literature. The Guide for Authors of JPBA contains the following restriction: "In determining the suitability of submitted articles for publication, particular scrutiny will be placed on the degree of novelty and significance of the research and the extent to which it adds to existing knowledge in pharmaceutical and biomedical analysis. In all submissions to the journal, authors must address the question of how their proposed methodology compares with previously reported methods." The authors have missed to make reference to closely related papers such as Ling Tong, Meixu Wan, Lihua Zhang, Yonghong Zhu, He Sun, Kaishun Bi, Simultaneous determination of baicalin, wogonoside, baicalein, wogonin, oroxylin A and chrysin of Radix scutellariae extract in rat plasma by liquid chromatography tandem mass spectrometry, Journal of Pharmaceutical and Biomedical Analysis (2012) (from the same university!!!) and Chung, H.J., Lim, S., Kim, I.S., Bu, Y., Kim, H., Kim, D.-H., Yoo, H.H., Simultaneous determination of baicalein, baicalin, wogonin, and wogonoside in rat plasma by LC-MS/MS for studying the pharmacokinetics of the standardized extract of scutellariae radix, Bulletin of the Korean Chemical Society, 33 (2012) 177-182. Reference has been made to [23] but real comparison was not made. |
金蟲(chóng) (小有名氣)
新蟲(chóng) (職業(yè)作家)
術(shù)中小生
|
我仔細(xì)看了審稿意見(jiàn)。 首先不要再投JPBA了,通過(guò)幾點(diǎn)老鼠,利用LC/MS進(jìn)行簡(jiǎn)單地鑒定入血成分,自去年JPBA就不收了。隨著IF的增長(zhǎng),其在代謝方面要求顯著提高。 審稿人認(rèn)為你的方法沒(méi)有什么特色,換句話說(shuō)你的發(fā)現(xiàn)沒(méi)有什么閃光點(diǎn)。另外一定得和已報(bào)道文獻(xiàn)進(jìn)行比對(duì),說(shuō)明你方法的先進(jìn)性。任何文章只報(bào)道自己東西,沒(méi)有和先前文獻(xiàn)對(duì)比的話,肯定是一短板。尤其遇到做過(guò)相關(guān)研究的審稿人,他認(rèn)變你沒(méi)有好好看文獻(xiàn)。 |
新蟲(chóng) (職業(yè)作家)
術(shù)中小生
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 085404 22408 315分 +5 | zhuangyan123 2026-03-31 | 6/300 |
|
|---|---|---|---|---|
|
[考研] 354求調(diào)劑 +3 | lxb598 2026-03-31 | 4/200 |
|
|
[考研] 化學(xué)工程085602 305分求調(diào)劑 +27 | RichLi_ 2026-03-25 | 31/1550 |
|
|
[考研] 求調(diào)劑 +7 | 11ggg 2026-03-30 | 7/350 |
|
|
[考研] 安徽大學(xué)專碩生物與醫(yī)藥專業(yè)(086000)324分,英語(yǔ)已過(guò)四六級(jí),六級(jí)521,求調(diào)劑 +5 | 美味可樂(lè)雞翅 2026-03-26 | 5/250 |
|
|
[考研] 一志愿中國(guó)科學(xué)院大學(xué)265求調(diào)劑 +6 | 恬淡ye 2026-03-31 | 7/350 |
|
|
[考研] 調(diào)劑求院校招收 +7 | 鶴鯨鴿 2026-03-28 | 7/350 |
|
|
[考研] 合肥區(qū)域性重點(diǎn)一本招收調(diào)劑 +4 | 6266jl 2026-03-30 | 4/200 |
|
|
[考研] 一志愿華東師范大學(xué)有機(jī)化學(xué)專業(yè),初試351分,復(fù)試被刷求調(diào)劑! +7 | 真名有冰 2026-03-29 | 8/400 |
|
|
[考研] 一志愿北京化工大學(xué)材料與化工(085600)296求調(diào)劑 +25 | 稻妻小編 2026-03-26 | 25/1250 |
|
|
[考研] 材料化工340求調(diào)劑 +3 | jhx777 2026-03-30 | 3/150 |
|
|
[考研] 322求調(diào)劑:一志愿湖南大學(xué) 材料與化工(085600),已過(guò)六級(jí)。 +9 | XX小鄧 2026-03-29 | 9/450 |
|
|
[基金申請(qǐng)] 面上5B能上會(huì)嗎? +7 | redcom 2026-03-29 | 7/350 |
|
|
[考研] 0703化學(xué)/290求調(diào)劑/本科經(jīng)歷豐富/工科也可 +13 | 丹青奶蓋 2026-03-26 | 15/750 |
|
|
[考研] 求調(diào)劑,一志愿 南京航空航天大學(xué)大學(xué) ,080500材料科學(xué)與工程學(xué)碩 +6 | @taotao 2026-03-26 | 7/350 |
|
|
[考研] 337求調(diào)劑 +6 | 《樹(shù)》 2026-03-29 | 6/300 |
|
|
[考研] 332求92調(diào)劑 +8 | 蕉蕉123 2026-03-28 | 8/400 |
|
|
[有機(jī)交流]
高溫高壓反應(yīng)求助
10+4
|
chibby 2026-03-25 | 4/200 |
|
|
[考研] 274求調(diào)劑 +17 | 顧九笙要謙虛 2026-03-24 | 23/1150 |
|
|
[考研] 314求調(diào)劑 +3 | 溪云珂 2026-03-26 | 3/150 |
|